97892-67-6

Usage

Uses

Used in Pharmaceutical Industry:
2-CHLORO-7-METHOXY-4-METHYL-QUINOLINE is used as a building block for the synthesis of various medications, contributing to the development of new drugs with potential therapeutic benefits.
Used in Antimalarial Applications:
2-CHLORO-7-METHOXY-4-METHYL-QUINOLINE has been studied for its potential antimalarial properties, making it a candidate for the development of treatments against malaria.
Used in Antibacterial Applications:
2-CHLORO-7-METHOXY-4-METHYL-QUINOLINE has also been investigated for its antibacterial properties, indicating its potential use in the development of antibiotics to combat bacterial infections.
Used in Dye and Pigment Production:
2-CHLORO-7-METHOXY-4-METHYL-QUINOLINE has been employed in the production of dyes and pigments, highlighting its versatility in different industries.

Upstream product

• 860297-02-5 2-chloro-4-methyl-quinolin-7-ol 
• 77-78-1 dimethyl sulfate 
• 40053-37-0 7-Methoxy-4-methylcarbostyril 

Downstream Products

• 6238-12-6 7-methoxy-4-methyl-quinoline 
• 860297-41-2 benzyl benzyl{(1R,2S,4S,6S)-6-[(7-methoxy-4-methylquinolin-2-yl)amino]bicyclo[2.2.1]hept-2-yl}carbamate 
• 97892-65-4 2-idrazino-4-metil-7-metossichinolina 

Relevant academic research and scientific papers

Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies

A series of 4-quinolylhydrazones was synthesized and tested in vitro against Mycobacterium tuberculosis. At a concentration of 6.25 μg/mL, most of the newly synthesized compounds displayed 100% inhibitory activity against M. tuberculosis in cellular assays. Further screening allowed the identification of very potent antitubercular agents. Compound 4c was also tested in a time-course experiment and against mtb clinical isolates, displaying interesting results.

THERAPEUTIC AGENTS I

Compounds of formula(I), processes for preparing such compounds, their use in the treatment of obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and related conditions, and neurological disorders such as dementia, multiple sclerosis, Parkinson's disease, Huntington's chorea and Alzheimer's disease and pain related disorders, and pharmaceutical compositions containing them.